back to Meetings page
- IMMPACT-VIII
- June 1-2, 2007
- Ritz Carlton Pentagon City
- Arlington, Virginia
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia Participants
- Jane C. Ballantyne, MD (Harvard University)
- Eugene Carragee, MD (Stanford University)
- Scott M. Croll, MD (Uniformed Services University and Walter Reed Army Medical Center)
- Paul J. Desjardins, DMD, PhD (Wyeth)
- John T. Farrar, MD (University of Pennsylvania)
- Ian Gilron, MD (Queen's University)
- Deborah B. Gordon, RN (University of Wisconsin)
- Eija A. Kalso, MD, PhD (Helsinki University, Finland)
- Nathaniel P. Katz, MD (Tufts University Medical School)
- Henrik Kehlet, MD, PhD (Rigshospitalet, Denmark)
- Michael P. McDermott, PhD (University of Rochester)
- Henry J. McQuay, MD (University of Oxford, United Kingdom)
- Srinivasa N. Raja, MD (Johns Hopkins University)
- Knox H. Todd, MD (Beth Israel Medical Center, New York)
- Mark S. Wallace, MD (University of California San Diego)
- Christopher Wu, MD (Johns Hopkins University)
- Government Participants
- Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
- Ann Costello, DMD, PhD (US Food and Drug Administration)
- Raymond Dionne, DDS, PhD (National Institute of Health)
- Sharon Hertz, MD (US Food and Drug Administration)
- Robert D. Kerns, PhD (Veterans Administration and Yale University)
- Mitchell B. Max, MD (National Institute of Health)
- Thomas J. Permutt, PhD (US Food and Drug Administration)
- Dionne Price, PhD (US Food and Drug Administration)
- Bob A. Rappaport, MD (US Food and Drug Administration)
- Patient Representative
- Penney Cowan (American Chronic Pain Association)
- Industry Participants
- David E. Blum, MD (GlaxoSmithKline)
- Arnold R. Gammaitoni, Pharm D (Merck & Company)
- Smriti Iyengar, PhD (Eli Lilly & Company)
- Gary W. Jay, MD (Schwarz Biosciences)
- Christine Rauschkolb, MD, PhD (Johnson & Johnson)
- Michael A. Royal, MD, JD (Cadence Pharmaceuticals)
- Marta Segerdahl, MD, PhD (AstraZeneca)
- Joseph W. Stauffer, DO (Alpharma)
- Trudy Vanhove, MD, PhD (NeurogesX, Inc.)
- Christine West, PhD (Pfizer)
- Richard E. White, PhD (Endo Pharmaceuticals)